U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128615) titled 'A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)' on Aug. 05.
Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of two investigational vaccines, AZD4117 and AZD5315 to protect against certain strains of avian Influenza A (H5N1 and H7N9 subtypes).
Study Start Date: Aug. 19
Study Type: INTERVENTIONAL
Condition:
Influenza A
Intervention:
BIOLOGICAL: AZD4117
Intramuscular (IM) injection
BIOLOGICAL: AZD5315
IM injection
OTHER: Placebo
IM injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services wit...